THE EFFECTS OF ASTEMIZOLE ON ANTIPYRINE CLEARANCE

被引：4

作者：

BATEMAN, DN

RAWLINS, MD

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 16卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1983.tb02262.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：759 / 760

页数：2

相关论文

共 6 条

[1] CHAPMAN PH, 1982, BRIT J CLIN PHARMACO, V13, pP593
[2] DAVIES DS, 1973, DRUG METAB DISPOS, V1, P411
[3] ASSESSMENT OF ANTIPYRINE KINETICS BY MEASUREMENT IN SALIVA
FRASER, HS
MUCKLOW, JC
MURRAY, S
DAVIES, DS
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) : 321 - 325
[4] PERFORMANCE STUDIES WITH THE H1-HISTAMINE RECEPTOR ANTAGONISTS, ASTEMIZOLE AND TERFENADINE
NICHOLSON, AN
STONE, BM
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (02) : 199 - 202
[5] MEASUREMENT OF URINARY 6-BETA-HYDROXYCORTISOL EXCRETION AS AN INVIVO PARAMETER IN THE CLINICAL-ASSESSMENT OF THE MICROSOMAL ENZYME-INDUCING CAPACITY OF ANTIPYRINE, PHENOBARBITONE AND RIFAMPICIN
OHNHAUS, EE
PARK, BK
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (02) : 139 - 145
[6] CLINICAL IMPLICATIONS OF ENZYME-INDUCTION AND ENZYME-INHIBITION
PARK, BK
BRECKENRIDGE, AM
[J]. CLINICAL PHARMACOKINETICS, 1981, 6 (01) : 1 - 24